Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Tylosin market, by Drug Type (Tylosin Phosphate, Tylosin Tartrate, and Others), by Application (Felines, Canines, and Livestock), by Route of Administration (Oral and Injectable), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published Date : Aug 2018

Tylosin Market – Insights Tylosin is an antibiotic that belongs to the class of macrolide antibiotics. It functions by binding to 50S ribosomal subunit and then interacts with 23S RNA thereby blocking a

Coherent Market Insights
Plant-based Vaccines Market, by Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, and Others), by Application (Influenza, Zika Virus, Ebola Virus, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Published Date : Dec 2018

Plant-based Vaccines Market - Insights Plant serves as an important source to produce cost-effective vaccine derivatives. Plant-based production of vaccine helps to reduce economic burden of infectious diseas

Coherent Market Insights
Scopolamine Market, by Dosage Form (Tablet, Syrup, Injection, Patch, and Others), by Distribution Channel (Hospital Pharmacies, Retail pharmacies, and Online Pharmacies) - Global Forecast to 2026

Published Date : Jul 2018

Scopolamine Market – Insights Scopolamine is an alkaloid drug extracted from plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamin

Coherent Market Insights
Triptorelin Market, by Product Type (Triptorelin pamoate, Triptorelin acetate, and Triptorelin embonate), by Application (Prostate Cancer, Radical Prostatectomy, Endometriosis, Salivary Gland Cancer and Central Precocious Puberty), By End User (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) - Global Forecast to 2026

Published Date : Jul 2018

Global Triptorelin Market – Global Industry Insights Gonadotropin-releasing hormone (GnRH) agonists have greater safety and efficacy profile than estrogens and anti-androgens among various therapies of

Coherent Market Insights
Rivaroxaban Market, by Strength (10 mg, 15 mg, and 20 mg), by Application (Deep Vein Thrombosis Prophylaxis and Pulmonary Embolism), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region - Global Forecast to 2026

Published Date : Jul 2018

Rivaroxaban Market Insights – Stop the Clot Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used i

Coherent Market Insights
Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2023

Published Date : Jul 2018

Global Primary Sclerosing Cholangitis Market – Efficient Treatment Targeting Orphan Disease Primary sclerosing cholangitis (PSC) is a condition cau

Coherent Market Insights
Nitric Oxide Synthase (NOS) Brain Market, by Product Type (Neuronal NOS (nNOS), Endothelial NOS (eNOS), and Inducible NOS (iNOS)), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jan 2019

Nitric oxide synthases (NOS) are group of enzymes, which convert L-arginine to L-citrulline and produce nitric oxide (NO). Nitric oxide synthases enzymes exhibit a bidomain structure homologous to cytochrome P450 reductase. There are three isoforms of NOS titled accor

Coherent Market Insights
Ramosetron Hydrochloride Market by Indication (Motion Sickness, Irritable Bowel Syndrome, Cancer Chemotherapy associated Nausea and Vomiting, and, Diarrhoea), by Application (Hospitals, Clinics, and Home Care), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Ramosetron hydrochloride, an anti-emetic drug, is prescribed for the treatment of diarrhoea-predominant irritable bowel syndrome in adults. Ramosetron hydrochloride is also prescribed for the treatment and management of postoperative nausea and/or vomiting and also as

Coherent Market Insights
Plasminogen Activator Inhibitor Market by Product Type 1 (Plasminogen Activator Inhibitor Type 1 (PAI-1), and Plasminogen Activator Inhibitor Type 2 (PAI-2)), by Application (Fibrinolysis, Cardiac Fibrosis, and Post-operative Wound Hematomas), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Plasminogen activator inhibitors also known as Serpin E1 is a protein present in the body whose elevated levels are responsible for thrombosis and atherosclerosis. (Plasminogen Activator Inhibitor Type 1 (PAI-1) is mainly secreted by the endothelium (cells lining blood vessels), and adipose tissu

Coherent Market Insights
Microneedle Flu Vaccine Market, by Vaccine Type (Trivalent Flu Vaccine and Quadrivalent Flu Vaccine), by Virus Type (Influenza Virus Type A and Influenza Virus Type B), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2018–2026

To Be Published : Jan 2019

Vaccine is one of the most important biologic product used to prevent from infection of various diseases such as seasonal influenza, hepatitis, polio, diphtheria, Japanese encephalitis, measles, meningococcal disease, tetanus, haemophilus influenza type b, whooping co

Coherent Market Insights
Sulfachloropyridazine Sodium Market by Patient Type (Cows, Pigs, Chickens, Cattles, and Pediatrics), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Sulfachloropyridazine sodium is a sulfonamide antibiotic used to study kinetics and reaction pathways. Also, it is used to treat acute Urinary Tract Infections (UTIs) in pediatric patients. Sulfachloropyridazine sodium blocks the synthesis of dihydrofolic acid by inhi

Coherent Market Insights
Prophylactic Human Vaccine Market, By Vaccine Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Polysaccharide Vaccines, Conjugate Vaccines, and Recombinant Vaccines), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Prophylactic human vaccines stimulate the immune response and are intended for ameliorating the effects of future infection caused by pathogens in human beings. Novel vaccine development technologies such as viral-like particles are used in developing Hepatitis B Viru

Coherent Market Insights
Polymer-drug Conjugates Market, by Product Type (PEG-a-interferon 2b, 1 PEG-L-asparaginase, and PEG-GCSF), by Application (Cancers, Hepatitis, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Polymer-drug conjugates are nano-sized drug products currently used for treating cancer and hepatitis. Polymers are now being synthesized to be sensitive to specific enzymes that are apparent in diseased tissue. Conventional polymers are used in polymer-drug conjugate

Coherent Market Insights
Roxithromycin Market, by Indication (Urinary and Soft Tissue Infections, Respiratory Tract Infections, Pneumonia, and Otitis Media, and Sinusitis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Roxithromycin, also known as arrow-roxithromycin, is a semi-synthetic macrolide antibiotic, which prevents bacterial growth by interfering with protein synthesis. The drug is indicated to treat certain types of bacterial infections such as pharyngitis, sinusitis, bron

Coherent Market Insights
Pertuzumab Market, by Indication (Early Breast Cancer and Metastatic Breast Cancer), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Pertuzumab is a recombinant monoclonal antibody that acts as an antineoplastic agent, which targets the human epidermal growth factor receptor 2 protein known as HER2. The drug blocks signaling pathways that leads to cell growth arrest and apoptosis (cell destruction)

Coherent Market Insights
Memantine Market, by Formulation (Tablet and Capsule), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Memantine is a non-acetyl cholinesterase inhibitor drug that aids in treatment of Alzheimer's disease. The drug received European marketing approval in 2002 and the U.S. Food and Drug Administration (U.S FDA) approval in 2003. The generic versions of the drugs are ava

Coherent Market Insights
Levodopa Market by Application (Parkinson’s disease and Dopamine Responsive Dystonia), by Drug Type (Rytary, Duopa, Sinemet, Canamet, and Others), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026.

To Be Published : Jan 2019

Levodopa or L-Dopa is a chemical building-block that converts into a dopamine in body. Dopamine is the chemical messenger released in brain. It mediates pleasure, cognition, and memory functions. Nearly all patients receive the dopamine precursor levodopa, which adequ

Coherent Market Insights
Fenbendazole Market, by Product Type (Powder, Tablet, and Liquid Formulations), by Application (Cattle, Sheep, Pig, Horse, Hens and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - SIze, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Fenbendazole is a broad spectrum anthelmintic drug of class benzimidazole. Fenbendazole is used to remove certain gastrointestinal parasites from the stomach and intestines of animals. It is effective against roundworms, hookworms, whipworms, certain tapeworms, and pa

Coherent Market Insights
Arginine Market, by Product Type (Food Grade and Pharma Grade), by Application (Supplements and Nutrition, Pharmaceuticals, and Cosmetics), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Jan 2019

Arginine, which is also known as L-arginine, is an essential amino acid for humans. Arginine is present in all protein-containing foods such as grains, beans, nuts, meat, dairy products, and eggs, and it is also synthesized in the body from glutamine via citrulline am

Coherent Market Insights
Focal Segmental Glomerulosclerosis Market by Disease Type (Primary Focal Segmental Glomerulosclerosis, and Secondary Focal Segmental Glomerulosclerosis), by Drug (Sparsentan (Phase III)), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Geography - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Focal Segmental Glomerulosclerosis (FSGS) is a rare kidney disease affecting the kidney's filtering system (glomeruli) and resulting in serious scarring and end stage renal disease. For instance, according to the article in Clinical Journal of American Society of Neph

Coherent Market Insights
Epidermolysis Bullosa Therapeutics Market, by Drugs (EB-101, Oleogel-S10 and Others), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

Epidermolysis Bullosa (EB) is a rare, genetic disorder of skin tissues. People suffering from EB have fragile skin, which is susceptible to blisters leading to wounds that are difficult to heal. Symptoms related to this disorder includes, blistering of skin,

Coherent Market Insights
ALK Positive Lung Cancer Treatment Market by Drugs (Crizotinib, Alectinib, Ceritinib, and Brigatinib), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Clinics), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Jan 2019

ALK positive lung cancer treatment is used for people suffering from lung cancer with Anaplastic Lymphoma Kinase (ALK) mutation (the EML4-ALK fusion gene). This gene mutation is due to gene rearrangement by fusion of two genes called as ALK and Echinoderm Microtubule-

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.